European stop tyrosine kinase inhibitor trial (EURO-SKI) in chronic myeloid leukemia: fanalysis and novel prognostic factors for treatment-free remission

MAHON, F.-X.; PFIRRMANN, M.; DULUCQ, S.; HOCHHAUS, A.; PANAYIOTIDIS, P.; ALMEIDA, A.; MAYER, J.; HJORTH-HANSEN, H.; JANSSEN, J.J.W.M.; MUSTJOKI, S.; MARTINEZ-LOPEZ, J.; VESTERGAARD, H.; EHRENCRONA, H.; MACHOVÁ POLÁKOVÁ, K.; ET AL. European stop tyrosine kinase inhibitor trial (EURO-SKI) in chronic myeloid leukemia: fanalysis and novel prognostic factors for treatment-free remission. Journal of clinical oncology. 2024, in press,. ISSN 0732-183X. SJR: 10.163, rok: 2022; Cite Score: 0.000; IF: 45.300, rok: 2022.